Article summary
Q2 2026 Federal Psychedelic Lobbying Update Now that federal lobbying data from the second quarter of the year is available to retrieve, we present our regular update on the state of activity across psychedelic drug developers and nonprofits. Psychedelics companies’ spending on lobbying firms at the federal level reached new heights in Q2 2026, though […]
Continue to the original publication for the complete article.